Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth.

Autor: Pulawska-Moon K; Institute of Biomedicine, University of Turku, Turku, Finland., Ponikwicka-Tyszko D; Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland., Lebiedzinska W; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland., Pilaszewicz-Puza A; Department of Pathomorphology, Medical University of Bialystok, Bialystok, Poland., Bernaczyk P; Department of Pathomorphology, Medical University of Bialystok, Bialystok, Poland., Koda M; Department of General Pathomorphology, Medical University of Bialystok, Bialystok, Poland., Lupu O; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland., Milewska G; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland., Huang CJ; Department of Anatomy, Physiology and Pharmacology, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA., Zheng H; Department of Anatomy, Physiology and Pharmacology, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA., Schiele P; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Na IK; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, and ECRC Experimental and Clinical Research Center, both Charité-Universitätsmedizin Berlin, Corporate members of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Berlin, Germany., Frentsch M; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Li X; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland.; State Key Laboratory of Agro-Biotechnology, China Agricultural University, Beijing, China., Toppari J; Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Pediatrics, Turku University Hospital, Turku, Finland., Wolczynski S; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland., Coelingh Bennink HJT; Pantarhei Oncology/Bioscience, Zeist, Netherlands., Huhtaniemi I; Institute of Biomedicine, University of Turku, Turku, Finland.; Institute of Reproductive and Developmental Biology, Imperial College London, London, UK., Rahman NA; Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Nov 15; Vol. 155 (10), pp. 1846-1857. Date of Electronic Publication: 2024 Jul 22.

Evidence that FGFR1 loss-of-function mutations may cause variable skeletal malformations in patients with Kallmann syndrome

Autor: Jarzabek, K, Wolczynski, S, Lesniewicz, R, Plessis, G, Kottler, ML

Publikováno v: In Advances in Medical Sciences 1 December 2012 57(2):314-321

The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome.

Autor: Liu Y; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China., Zhang S; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China., Chen L; Department of Reproductive Medicine, Affiliated Jinling Hospital, Medicine School of Nanjing University, Nanjing, Jiangsu, China., Huang X; Department of Reproductive Medicine, Affiliated Jinling Hospital, Medicine School of Nanjing University, Nanjing, Jiangsu, China., Wang M; Xuzhou Medical University, School of Basic Medical Sciences, Xuzhou, Jiangsu, China., Ponikwicka-Tyszko D; Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland; Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland., Rahman NA; Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland., Wolczynski S; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland., Yao B; Department of Reproductive Medicine, Affiliated Jinling Hospital, Medicine School of Nanjing University, Nanjing, Jiangsu, China. Electronic address: yaobing@nju.edu.cn., Li X; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, Poland; Hainan Sanya Research Institute, Seed Laboratory, Sanya, China. Electronic address: xiangdongli68@126.com.

Publikováno v: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2023 Jun; Vol. 256, pp. 1-13. Date of Electronic Publication: 2022 Dec 28.

Role and mechanism of miR-335-5p in the pathogenesis and treatment of polycystic ovary syndrome.

Autor: Zhang S; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China., Liu Y; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China; Hainan Yazhou Bay Seed Lab., Wang M; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China., Ponikwicka-Tyszko D; Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland; Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland., Ma W; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China., Krentowska A; Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Bialystok, Poland., Kowalska I; Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Bialystok, Poland., Huhtaniemi I; Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland; Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, UK., Wolczynski S; Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok, 15276, Poland., Rahman NA; Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland; Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, UK., Li X; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China; Hainan Yazhou Bay Seed Lab; Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, UK; Department of Nutrition and Health, China Agricultural University, Beijing, China. Electronic address: xiangdongli68@126.com.

Publikováno v: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2023 Feb; Vol. 252, pp. 64-78. Date of Electronic Publication: 2022 Aug 02.

Hyaluronic acid counteracts interleukin-1-induced inhibition of collagen biosynthesis in cultured human chondrocytes

Autor: Karna, E., Miltyk, W., Pałka, J.A., Jarząbek, K., Wołczyński, S.

Publikováno v: In Pharmacological Research 2006 54(4):275-281